Juan Camarillo

Research Scientist at Usc Roski Eye Institute

Juan Camarillo's Professional Contact Details

Email (Verified)
****
HQ
(800) 872-2273
Location
Alhambra, California, US
Company
Usc Roski Eye Institute
Person Seniority
entry

Juan Camarillo's Current Company Details

The USC Roski Eye Institute, Keck School of Medicine, with full-time faculty physicians covering all subspecialties of ophthalmology. In 1974, the USC Keck School of Medicine established the USC Depar...
The USC Roski Eye Institute, Keck School of Medicine, with full-time faculty physicians covering all subspecialties of ophthalmology. In 1974, the USC Keck School of Medicine established the USC Department of Ophthalmology, which grew into the USC Roski Eye Institute, becoming an essential regional, national and global leader in the field. Recognized by U.S. News & World Report and Ophthalmology Times, The USC Roski Eye Institute and the Department of Ophthalmology has been ranked in the top 10 ophthalmology programs in the country for the past 21 years. The USC Roski Eye Institute is headquartered near downtown Los Angeles and has clinics in Pasadena, Beverly Hills and Arcadia. For more information, visit usceye.org. OUR VISION IS OUR MISSION PROTECTING USC Roski Eye Institute leads major research in the epidemiology of eye disease to help prevent blindness. PRESERVING USC Roski Eye Institute diagnoses, treats and manages the most complex eye conditions, from in utero to advanced age. RESTORING USC Roski Eye Institute integrates and applies emerging technologies to develop new methods to restore sight to the blind. We have made it our mission to restore sight and make dramatic improvements in the quality of our patients' lives. Major breakthroughs • Changing health care policy in America -our world-renowned community health studies assess eye diseases for to treatment and prevention initiatives • Pioneered use of ultra-high speed Fournier domain optical coherence tomography (OCT) for advanced diagnosis • Invention of the world's first FDA approved artificial retina, Argus II- brought an unprecedented degree of sight back to those with a form of retinal blindness • Discovery of a new stem cell therapy for age-related macular degeneration • Discovered which retinal cells mutate to become retinoblastoma-the most common type of eye cancer in children
Founded Year
1974
Organization Website
usceye.org
Organization Languages
English
Current Technologies
gmail
google apps
godaddy hosting
wufoo
twitter advertising
itunes
crazyegg
shutterstock
doubleclick floodlight
nginx
yandex metrika
ubuntu
youtube
google analytics
wordpress org
google play
facebook web custom audiences
doubleclick
bootstrap framework
google tag manager
jquery 1 11 1
google font api
wordpress com
recaptcha
facebook login
mobile friendly
hotjar
facebook widget
callrail

Job Functions

Education
Operations
Information Technology
oculoplastic
glaucoma
comprehensive ophthalmology
neuroophthalmology
pediatric ophthalmology
retina
cornea & external diseases
hospital & health care

Juan Camarillo's Work History and Education

USC Roski Eye Institute
Research Scientist
2015 - Present

Colleagues at Usc Roski Eye Institute

Regional Operations Director, Ambulatory Services
Assistant Professor of Ophthalmology
Assistant Professor of Ophthalmology Research

Prospect on LinkedIn

Find emails on Linkedln, Sales Navigator, AngelList, CrunchBase, Google etc.
Download Extension Represents linkedin prospector

Ready to try it out?